Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Pharmacology of KB-R7943: a Na+-Ca2+ exchange inhibitor Amran MS; Homma N; Hashimoto KCardiovasc Drug Rev 2003[Win]; 21 (4): 255-76The Na+-Ca2+ exchange (NCX) system plays a pivotal role in regulating intracellular Ca2+ concentration in cardiomyocytes, neuronal cells, kidney and a variety of other cells. It performs a particularly important function in regulating cardiac contractility and electrical activity. One of the leading NCX inhibitors is KB-R9743 (KBR) that appears to exhibit selectivity for Ca2+-influx-mode NCX activity (reverse mode of NCX). In this article we reviewed pharmacology of KBR and provide a brief summary of studies with other NCX inhibitors, such as SEA0400 (SEA) and SN-6 (SN). Potential clinical usefulness of KBR and other NCX inhibitors is still controversial but the reviewed findings may be helpful in designing more selective and clinically useful NCX inhibitors for the treatment of cardiac, neuronal and kidney diseases.|*Anti-Arrhythmia Agents/adverse effects/pharmacology/therapeutic use[MESH]|*Thiourea/adverse effects/*analogs & derivatives/pharmacology/therapeutic use[MESH]|Action Potentials/drug effects[MESH]|Acute Kidney Injury/*drug therapy[MESH]|Animals[MESH]|Humans[MESH]|Reperfusion Injury/*prevention & control[MESH]|Sodium-Calcium Exchanger/*antagonists & inhibitors/physiology[MESH] |
